Further work is necessary to resolve the conflicts in the literature surrounding PD-1/PD-L1 inhibitors in obesity, and interventional studies involving the microbiome might be an interesting approach. This evidence concerns the gene CD274 and obesity due to melanocortin 4 receptor deficiency.